send to a friend by email
2011-11-01
The Palestine Exchange (PEX) received the unaudited
interim consolidated condensed financial statements from
Jerusalem Pharmaceuticals (
JPH). The PEX disclosure rules in place give all of the PEX listed companies a period of one month to report their third quarter interim financial statements as reviewed by the company’s internal auditor. Their disclosure has been published on the PEX website (www.pex.ps) and emailed to PEX member securities firms in conjunction with this press release.
The disclosed information includes: the Statement of Financial Position,
the Income Statement, Changes in Equity Ownership, and the Statement of Cash Flows. Notes to the interim financial statements were not provided. The company also provided its interim financial statements via the approved electronic form of disclosure applicable to the
Industry Sector. The interim report should also include information required by Article (37/2) of the PEX disclosure rules in place. The company
included information regarding management, issued shares, material changes and significant events that may have affected financial performances during the first nine months of the year.
According to company data for the first nine months of the year, net
profit before taxes reached 2,236,730
JOD, compared with a net
profit before taxes of 2,491,898
JOD from the first nine months of
2010, a net
decrease of
10.2%. Total assets of the company have reached 28,866,457
JOD as of September 30th,
2011, compared to total assets of 28,745,051
JOD as of December 31st,
2010, a net
increase of
0.4%. Total liabilities of the company have reached 5,836,791
JOD as of September 30th,
2011, compared to total liabilities of 6,187,869
JOD as of December 31st,
2010, a net
decrease of
5.7%. Net ownership equity of the company has reached 23,029,666
JOD (including 67,650 JOD in Minority Rights) as of September 30th,
2011, compared with a net ownership equity of 22,557,182
JOD (including 76,538 JOD in Minority Rights) as of December 31st,
2010, a net
increase of
2.1% in the last nine months.
|
|